Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,268 | 138 | 95.0% |
| Education | $120.36 | 3 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $494.12 | 30 | $0 (2021) |
| Hologic, LLC | $390.08 | 17 | $0 (2022) |
| ABBVIE INC. | $316.67 | 21 | $0 (2024) |
| PFIZER INC. | $200.03 | 14 | $0 (2023) |
| Duchesnay USA Incorporated | $131.83 | 9 | $0 (2018) |
| Channel Medsystems, Inc. | $96.62 | 1 | $0 (2024) |
| Allergan, Inc. | $84.29 | 7 | $0 (2020) |
| Radius Health, Inc. | $82.48 | 4 | $0 (2024) |
| Mission Pharmacal Company | $81.12 | 5 | $0 (2019) |
| Astellas Pharma US Inc | $73.67 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $304.45 | 13 | Channel Medsystems, Inc. ($96.62) |
| 2023 | $161.31 | 10 | PFIZER INC. ($44.58) |
| 2022 | $370.86 | 14 | Hologic, LLC ($190.85) |
| 2021 | $36.91 | 3 | Hologic, LLC ($24.22) |
| 2020 | $195.72 | 8 | Amgen Inc. ($164.74) |
| 2019 | $355.76 | 24 | Hologic, LLC ($93.38) |
| 2018 | $469.47 | 35 | Duchesnay USA Incorporated ($112.02) |
| 2017 | $493.90 | 34 | Amgen Inc. ($136.20) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $20.14 | General |
| 09/09/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: WOMENS HEALTH | ||||||
| 05/15/2024 | CooperSurgical, Inc. | WALLACH Cryosurgical Equipment (Device) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Not Applicable | ||||||
| 04/30/2024 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $96.62 | General |
| 04/23/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Endocrinology | ||||||
| 04/07/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: WOMENS HEALTH | ||||||
| 03/27/2024 | Monaghan Medical Corporation | AeroChamber (Device) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Chamber | ||||||
| 03/19/2024 | Northgate Technologies, Inc. | Stimsite (Device) | Food and Beverage | Cash or cash equivalent | $17.96 | General |
| Category: General Surgery | ||||||
| 03/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Biological | ||||||
| 02/20/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Endocrinology | ||||||
| 01/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Biological | ||||||
| 01/17/2024 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| 01/09/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Urology | ||||||
| 10/11/2023 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| 10/10/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Endocrinology | ||||||
| 08/16/2023 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: WOMENS HEALTH | ||||||
| 08/01/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Urology | ||||||
| 06/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Biological | ||||||
| 04/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Urology | ||||||
| 03/28/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: WOMENS HEALTH | ||||||
| 02/22/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: WOMENS HEALTH | ||||||
| 01/24/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: WOMENS HEALTH | ||||||
| 12/28/2022 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: WOMENS HEALTH | ||||||
| 11/08/2022 | Mylan Pharmaceuticals Inc. | Xulane (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Contraceptives, Transdermal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 503 | 1,510 | $64,380 | $33,293 |
| 2022 | 7 | 450 | 3,020 | $103,050 | $57,309 |
| 2021 | 7 | 474 | 3,345 | $99,115 | $61,438 |
| 2020 | 7 | 408 | 2,078 | $65,241 | $37,932 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,020 | $30,600 | $17,630 | 57.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 119 | 119 | $7,735 | $4,240 | 54.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 79 | 79 | $3,950 | $3,083 | 78.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 52 | $6,500 | $3,041 | 46.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 79 | 79 | $9,875 | $2,659 | 26.9% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 144 | 144 | $5,040 | $2,547 | 50.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 17 | $680.00 | $92.88 | 13.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 27 | 2,580 | $77,100 | $44,094 | 57.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 124 | 124 | $8,060 | $4,585 | 56.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 81 | 81 | $4,050 | $3,242 | 80.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 132 | 132 | $4,620 | $2,350 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 23 | $2,875 | $1,404 | 48.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 37 | 37 | $4,625 | $1,260 | 27.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 43 | $1,720 | $373.94 | 21.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 29 | 2,880 | $71,940 | $47,284 | 65.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 127 | 127 | $8,254 | $4,718 | 57.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 94 | 94 | $4,699 | $3,810 | 81.1% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 134 | 134 | $4,689 | $2,419 | 51.6% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 41 | 41 | $4,675 | $1,443 | 30.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 21 | $2,940 | $1,304 | 44.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 30 | 48 | $1,918 | $460.10 | 24.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 21 | 1,680 | $41,940 | $25,994 | 62.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 116 | 116 | $7,539 | $4,339 | 57.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 64 | 64 | $3,200 | $2,558 | 79.9% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 126 | 126 | $4,399 | $2,268 | 51.5% |
About Dr. Winston Ashurst, MD
Dr. Winston Ashurst, MD is a Obstetrics & Gynecology healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396714176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Winston Ashurst, MD has received a total of $2,388 in payments from pharmaceutical and medical device companies, with $304.45 received in 2024. These payments were reported across 141 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,268).
As a Medicare-enrolled provider, Ashurst has provided services to 1,835 Medicare beneficiaries, totaling 9,953 services with total Medicare billing of $189,972. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Montgomery, AL
- Active Since 03/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1396714176
Products in Payments
- Prolia (Biological) $216.75
- ACESSA PROVU SYSTEM (Device) $202.07
- LO LOESTRIN FE (Drug) $154.46
- PREMARIN (Drug) $147.16
- EVENITY (Biological) $130.94
- Osphena (Drug) $112.02
- Novasure (Device) $74.19
- Orilissa (Drug) $72.44
- Tymlos (Drug) $68.40
- Lupron (Drug) $59.77
- CitraNatal (Drug) $51.07
- Vitafol Ultra (Drug) $45.04
- Veozah (Drug) $44.64
- PVC (Drug) $39.60
- Da Vinci Surgical System (Device) $33.02
- VIIBRYD (Drug) $32.94
- MAKENA (Drug) $32.36
- AJOVY (Drug) $32.24
- Fluent (Device) $31.15
- UBRELVY (Drug) $29.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Montgomery
Rebecca Stewart Miller, Md, MD
Obstetrics & Gynecology — Payments: $9,613
Dr. Ralph Garrard, Md, MD
Obstetrics & Gynecology — Payments: $6,942
Dr. Jennifer Logan, Md, MD
Obstetrics & Gynecology — Payments: $6,586
Dr. Anika Moore, Md, MD
Obstetrics & Gynecology — Payments: $6,434
Ian Foley, Md, MD
Obstetrics & Gynecology — Payments: $6,295
Julia Lee, Md, MD
Obstetrics & Gynecology — Payments: $6,280